ORLANDO, Fla.--(BUSINESS WIRE)--Regulatory News:
Elekta (STO:EKTAB), a leading provider of technology for treating cancer and neurological conditions, today introduced Extend™*, a new stereotactic treatment program that lets neurosurgeons and radiation oncologists apply the proven power and precision of Gamma Knife® surgery to an even broader class of targets in the head and neck*.
